Marcio Nattan Portes Souza
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Marcio Nattan Portes Souza has a total of 201 co-authors. Here are the top co-authors by number of shared publications:
- Mario Fernando Prieto Peres
University of São Paulo, São Paulo, São Paulo, Brazil
8 shared publications - Cristina Tassorelli
University of Pavia
6 shared publications - Ida Fortini
Universidade de São Paulo, Faculdade de Medicina, Hospital das Clínicas, Divisão de Neurologia, São Paulo SP, Brazil
6 shared publications - Sait Ashina
Harvard Medical School
6 shared publications - David García-Azorín
Headache Unit, Department of Neurology, Hospital Universitario Río Hortega de Valladolid, Valladolid, Spain
5 shared publications - Francesca Puledda
King's College London
5 shared publications
Latest Publications
- Open Access
- 21 October 2026
- Published by SAGE Publications in Cephalalgia Reports
- Vol. 9
Optimizing headache history-taking: A structured approach from the International Headache Society Education Committee
Background: Headache disorders are among the most prevalent and disabling conditions worldwide. Diagnosis of primary headache disorders, including migraine, depends largely on clinical history and neurological examination, while secondary headaches require timely recognition of alarm signs. In routine practice, suboptimal communication can lead to incomplete histories and misalignment between patient experience and clinician assessment of key variables such as frequency, disability, and risk features. A systematic approach is needed to integrate diagnostic frameworks with patient-centered communication to elicit accurate information while maintaining rapport. Methods: We conducted a narrative review and expert consensus from the International Headache Society Education Committee to outline a structured approach to headache history-taking. Results: The proposed framework begins with early rapport-building using open-ended prompts and active listening to capture the patient's narrative. It then guides a structured characterization of headache presentations (quality, intensity, timing, associated symptoms, triggers, and disability), alongside targeted screening for secondary headache warning features using the SNNOOP10 framework and temporal pattern analysis. The framework incorporates validated outcome measures (e.g., MIDAS, HIT-6), assessment of psychiatric and social context, and use of headache diaries to support longitudinal monitoring and treatment optimization. Pediatric adaptations address developmental stage, caregiver participation, and age-appropriate assessment of disability and red flags. The review also discusses digital and AI-enabled tools to support pre-visit history capture, headache diary analytics, and structured clinical documentation. Conclusion: A structured, empathic history remains the cornerstone of headache medicine and the primary tool for distinguishing primary from secondary disorders. Integrating ICHD-3–based diagnostic reasoning with patient-centered communication and standardized measurement tools may strengthen therapeutic partnership, improve adherence, and support more judicious use of investigations.
- 21 October 2026
- Published by SAGE Publications in Cephalalgia Reports
- Vol. 9
Open AccessOptimizing headache history-taking: A structured approach from the International Headache Society Education Committee
Background: Headache disorders are among the most prevalent and disabling conditions worldwide. Diagnosis of primary headache disorders, including migraine, depends largely on clinical history and neurological examination, while secondary headaches require timely recognition of alarm signs. In routine practice, suboptimal communication can lead to incomplete histories and misalignment between patient experience and clinician assessment of key variables such as frequency, disability, and risk features. A systematic approach is needed to integrate diagnostic frameworks with patient-centered communication to elicit accurate information while maintaining rapport. Methods: We conducted a narrative review and expert consensus from the International Headache Society Education Committee to outline a structured approach to headache history-taking. Results: The proposed framework begins with early rapport-building using open-ended prompts and active listening to capture the patient's narrative. It then guides a structured characterization of headache presentations (quality, intensity, timing, associated symptoms, triggers, and disability), alongside targeted screening for secondary headache warning features using the SNNOOP10 framework and temporal pattern analysis. The framework incorporates validated outcome measures (e.g., MIDAS, HIT-6), assessment of psychiatric and social context, and use of headache diaries to support longitudinal monitoring and treatment optimization. Pediatric adaptations address developmental stage, caregiver participation, and age-appropriate assessment of disability and red flags. The review also discusses digital and AI-enabled tools to support pre-visit history capture, headache diary analytics, and structured clinical documentation. Conclusion: A structured, empathic history remains the cornerstone of headache medicine and the primary tool for distinguishing primary from secondary disorders. Integrating ICHD-3–based diagnostic reasoning with patient-centered communication and standardized measurement tools may strengthen therapeutic partnership, improve adherence, and support more judicious use of investigations.
- Open Access
- 8 October 2026
- Published by SAGE Publications in Cephalalgia Reports
- Vol. 9
Introducing Masterclass in Headache: A new educational series from Cephalalgia Reports
- 8 October 2026
- Published by SAGE Publications in Cephalalgia Reports
- Vol. 9
Open AccessIntroducing Masterclass in Headache: A new educational series from Cephalalgia Reports
- Open Access
- 12 September 2026
- Published by SAGE Publications in Cephalalgia
- Vol. 46 (9)
Establishing a core curriculum in headache medicine: Best practices from the international headache society education committee
Headache disorders remain one of the most disabling and prevalent neurological diseases worldwide. Headache medicine and care have evolved tremendously over the past few years. In order to foster adequate education in headache medicine in medical school curricula and clinical residency programs, the Education Committee of the International Headache Society (IHS) updated the core curriculum in headache medicine for establishing core competencies in general neurologists and headache specialists. This document describes the background and methodical approach of the IHS in developing and updating the current core curriculum in headache medicine and presents the output of the endeavor. The process has been guided by international expert consultation, evidence-based content development, and alignment with evolving scientific and clinical advances. The 2026 updated Core Curriculum outlines a tiered approach for general neurologists and headache specialists, which includes advances in pathophysiology, diagnosis, therapeutics, multidisciplinary management, and internationally transferable training standards. This revised core curriculum will guide headache education worldwide and enable higher-quality patient care across a range of healthcare settings.
- 12 September 2026
- Published by SAGE Publications in Cephalalgia
- Vol. 46 (9)
Open AccessEstablishing a core curriculum in headache medicine: Best practices from the international headache society education committee
Headache disorders remain one of the most disabling and prevalent neurological diseases worldwide. Headache medicine and care have evolved tremendously over the past few years. In order to foster adequate education in headache medicine in medical school curricula and clinical residency programs, the Education Committee of the International Headache Society (IHS) updated the core curriculum in headache medicine for establishing core competencies in general neurologists and headache specialists. This document describes the background and methodical approach of the IHS in developing and updating the current core curriculum in headache medicine and presents the output of the endeavor. The process has been guided by international expert consultation, evidence-based content development, and alignment with evolving scientific and clinical advances. The 2026 updated Core Curriculum outlines a tiered approach for general neurologists and headache specialists, which includes advances in pathophysiology, diagnosis, therapeutics, multidisciplinary management, and internationally transferable training standards. This revised core curriculum will guide headache education worldwide and enable higher-quality patient care across a range of healthcare settings.
- Open Access
- 27 April 2026
- Published by SAGE Publications in Cephalalgia Reports
- Vol. 9
The value of nonfactual information in distinguishing primary from secondary headache disorders results of a Delphi study
Objective: To collect pairs of nonfactual information and their interpretations and rate their usefulness in distinguishing between primary and secondary headache disorders. Background: Physicians use clinical indicators such as Red Flags and ask about exposure to potential causes to differentiate primary from secondary headaches; however, these approaches have limitations and may result in unnecessary diagnostic procedures. Methods: Using the Delphi process, the participants proposed information-interpretation pairs in the first round and rated them anonymously in two subsequent rounds. The ratings relied on quality estimators to evaluate the reliability, validity, relevance, and frequency on 5-point Likert scales, ranging from 0 to 5. We considered pairs with an average rating of 4.0 or higher to have reached consensus. Results: Four proposals reached consensus, of which two referred to nonfactual information: (i) “A headache that feels familiar indicates a primary headache.” (ii) “A headache that feels completely different from any previous headache raises the suspicion of a secondary headache.” Conclusions: The participants generally found little use for nonfactual information for distinguishing between primary and secondary headache disorders. Solely the presence and absence of patients’ notion of a familiar headache were deemed helpful. While the participants viewed the former as being associated with a primary headache, they felt that the latter pointed towards a secondary headache. Further research is necessary to evaluate their usefulness in clinical practice.
- 27 April 2026
- Published by SAGE Publications in Cephalalgia Reports
- Vol. 9
Open AccessThe value of nonfactual information in distinguishing primary from secondary headache disorders results of a Delphi study
Objective: To collect pairs of nonfactual information and their interpretations and rate their usefulness in distinguishing between primary and secondary headache disorders. Background: Physicians use clinical indicators such as Red Flags and ask about exposure to potential causes to differentiate primary from secondary headaches; however, these approaches have limitations and may result in unnecessary diagnostic procedures. Methods: Using the Delphi process, the participants proposed information-interpretation pairs in the first round and rated them anonymously in two subsequent rounds. The ratings relied on quality estimators to evaluate the reliability, validity, relevance, and frequency on 5-point Likert scales, ranging from 0 to 5. We considered pairs with an average rating of 4.0 or higher to have reached consensus. Results: Four proposals reached consensus, of which two referred to nonfactual information: (i) “A headache that feels familiar indicates a primary headache.” (ii) “A headache that feels completely different from any previous headache raises the suspicion of a secondary headache.” Conclusions: The participants generally found little use for nonfactual information for distinguishing between primary and secondary headache disorders. Solely the presence and absence of patients’ notion of a familiar headache were deemed helpful. While the participants viewed the former as being associated with a primary headache, they felt that the latter pointed towards a secondary headache. Further research is necessary to evaluate their usefulness in clinical practice.
- Open Access
- 17 March 2026
- Published by SAGE Publications in Cephalalgia
- Vol. 46 (3)
Virtual teaching for headache education: Is this the way to go?
- 17 March 2026
- Published by SAGE Publications in Cephalalgia
- Vol. 46 (3)
Open AccessVirtual teaching for headache education: Is this the way to go?
- Open Access
- 30 January 2026
- Published by Headache Medicine in Headache Medicine
- Vol. 17 (1) , 75-85
Update on spontaneous intracranial hypotension
Background Spontaneous intracranial hypotension (SIH) is a secondary headache disorder caused by spontaneous cerebrospinal fluid (CSF) leakage, typically from dural tears, meningeal diverticula, or CSF venous fistulas, in the absence of preceding trauma or procedures. Although increasingly recognized, SIH remains underdiagnosed and frequently mistaken for primary headache syndromes. MethodsThis narrative review synthesizes current evidence on the epidemiology, pathophysiology, clinical manifestations, neuroimaging features, complications, and management of SIH. Recent literature and expert consensus were analyzed to integrate advances in imaging-based diagnosis and leak type specific therapeutic strategies. ResultsSIH arises from low CSF volume rather than true hypotension, leading to brain descent, venous engorgement, and the characteristic MRI features summarized by the SEEPS mnemonic: subdural collections, pachymeningeal enhancement, venous engorgement, pituitary enlargement, and brain sagging. Orthostatic headache is the hallmark symptom, though up to 15% of patients lack clear positional features. Associated symptoms include vestibulocochlear disturbances, neck or interscapular pain, cranial nerve palsies, and cognitive or motor dysfunction. Brain and whole spine MRI are first line diagnostic tools. MR myelography distinguishes SLEC positive (types 1 and 2) from SLEC negative (type 3) leaks, guiding targeted myelography with dynamic CT or digital subtraction techniques for leak localization. Treatment should be tailored to leak type and site: epidural blood or fibrin patching for dural and diverticular leaks, and transvenous embolization for CSF venous fistulas. Surgical repair is reserved for refractory or anatomically complex cases. Reported complications include subdural hematoma, cerebral venous thrombosis, superficial siderosis, and bibrachial amyotrophy. ConclusionsSIH represents a heterogeneous spinal disorder with intracranial manifestations. Early recognition, standardized imaging algorithms, and multidisciplinary management are crucial to improving outcomes. Ongoing research into imaging biomarkers, predictors of response, and consensus based care pathways will help advance precision medicine in SIH.
- 30 January 2026
- Published by Headache Medicine in Headache Medicine
- Vol. 17 (1) , 75-85
Open AccessUpdate on spontaneous intracranial hypotension
Background Spontaneous intracranial hypotension (SIH) is a secondary headache disorder caused by spontaneous cerebrospinal fluid (CSF) leakage, typically from dural tears, meningeal diverticula, or CSF venous fistulas, in the absence of preceding trauma or procedures. Although increasingly recognized, SIH remains underdiagnosed and frequently mistaken for primary headache syndromes. MethodsThis narrative review synthesizes current evidence on the epidemiology, pathophysiology, clinical manifestations, neuroimaging features, complications, and management of SIH. Recent literature and expert consensus were analyzed to integrate advances in imaging-based diagnosis and leak type specific therapeutic strategies. ResultsSIH arises from low CSF volume rather than true hypotension, leading to brain descent, venous engorgement, and the characteristic MRI features summarized by the SEEPS mnemonic: subdural collections, pachymeningeal enhancement, venous engorgement, pituitary enlargement, and brain sagging. Orthostatic headache is the hallmark symptom, though up to 15% of patients lack clear positional features. Associated symptoms include vestibulocochlear disturbances, neck or interscapular pain, cranial nerve palsies, and cognitive or motor dysfunction. Brain and whole spine MRI are first line diagnostic tools. MR myelography distinguishes SLEC positive (types 1 and 2) from SLEC negative (type 3) leaks, guiding targeted myelography with dynamic CT or digital subtraction techniques for leak localization. Treatment should be tailored to leak type and site: epidural blood or fibrin patching for dural and diverticular leaks, and transvenous embolization for CSF venous fistulas. Surgical repair is reserved for refractory or anatomically complex cases. Reported complications include subdural hematoma, cerebral venous thrombosis, superficial siderosis, and bibrachial amyotrophy. ConclusionsSIH represents a heterogeneous spinal disorder with intracranial manifestations. Early recognition, standardized imaging algorithms, and multidisciplinary management are crucial to improving outcomes. Ongoing research into imaging biomarkers, predictors of response, and consensus based care pathways will help advance precision medicine in SIH.
- Open Access
- 23 January 2026
- Published by SAGE Publications in Cephalalgia
- Vol. 46 (1)
2025 Highlights in acute migraine treatment
- 23 January 2026
- Published by SAGE Publications in Cephalalgia
- Vol. 46 (1)
Open Access2025 Highlights in acute migraine treatment
- 3 January 2026
- Published by Springer Nature
- p. 293-303
Headache Attributed to Low Cerebrospinal Fluid (CSF) Pressure
- 3 January 2026
- Published by Springer Nature
- p. 293-303
Headache Attributed to Low Cerebrospinal Fluid (CSF) Pressure
- Open Access
- 29 December 2025
- Published by Georg Thieme Verlag KG in Arquivos Brasileiros de Neurocirurgia: Brazilian Neurosurgery
- Vol. 44 (04) , e292-e297
Refractory Headache in Macroprolactinoma Resolved After Neurosurgery: A Challenging Clinical Case and Literature Review
Pituitary tumors are present in approximately 15% of the population and are often discovered incidentally during imaging for headache evaluation. Headaches are prevalent in patients with pituitary adenomas, occurring in 37-70% of cases. However, determining whether the tumor itself causes the pain is frequently challenging. A 27-year-old woman presented with progressive daily holocranial headaches, photophobia, phonophobia, nausea, and secondary amenorrhea. Laboratory tests and pituitary imaging confirmed a macroprolactinoma. Initial treatment with cabergoline and bromocriptine was unsuccessful due to intolerable side effects. Transsphenoidal surgery produced marked clinical improvement and a partial reduction in serum prolactin. However, tumor regrowth occurred with recurrence of daily headaches, and a second surgery was delayed due to the COVID-19 pandemic. Multiple medical treatments, which included topiramate, divalproex sodium, amitriptyline, propranolol, and riboflavin with magnesium resulted in no improvement. After the second neurosurgery, she presented normoprolactinemia with no residual tumor and once again a complete resolution of the headache episodes. Risk factors for headache related to adenoma include high prolactin or IGF-1 levels, cavernous sinus invasion (but not adenoma size), and a history of primary headache disorder. International diagnosis criteria emphasize headache resolution following endocrine normalization or tumor removal. This case highlights the intricate relationship between prolactinomas and headaches, underscoring the need for individualized treatment strategies.
- 29 December 2025
- Published by Georg Thieme Verlag KG in Arquivos Brasileiros de Neurocirurgia: Brazilian Neurosurgery
- Vol. 44 (04) , e292-e297
Open AccessRefractory Headache in Macroprolactinoma Resolved After Neurosurgery: A Challenging Clinical Case and Literature Review
Pituitary tumors are present in approximately 15% of the population and are often discovered incidentally during imaging for headache evaluation. Headaches are prevalent in patients with pituitary adenomas, occurring in 37-70% of cases. However, determining whether the tumor itself causes the pain is frequently challenging. A 27-year-old woman presented with progressive daily holocranial headaches, photophobia, phonophobia, nausea, and secondary amenorrhea. Laboratory tests and pituitary imaging confirmed a macroprolactinoma. Initial treatment with cabergoline and bromocriptine was unsuccessful due to intolerable side effects. Transsphenoidal surgery produced marked clinical improvement and a partial reduction in serum prolactin. However, tumor regrowth occurred with recurrence of daily headaches, and a second surgery was delayed due to the COVID-19 pandemic. Multiple medical treatments, which included topiramate, divalproex sodium, amitriptyline, propranolol, and riboflavin with magnesium resulted in no improvement. After the second neurosurgery, she presented normoprolactinemia with no residual tumor and once again a complete resolution of the headache episodes. Risk factors for headache related to adenoma include high prolactin or IGF-1 levels, cavernous sinus invasion (but not adenoma size), and a history of primary headache disorder. International diagnosis criteria emphasize headache resolution following endocrine normalization or tumor removal. This case highlights the intricate relationship between prolactinomas and headaches, underscoring the need for individualized treatment strategies.
- Open Access
- 20 June 2025
- Published by Springer Nature in Neurology and Therapy
- Vol. 14 (4) , 1229-1268
From Headache to Heart Health: Investigating the Migraine–Cardiovascular Disease Connection
Migraine, particularly with aura, has been consistently associated with an increased risk of cardiovascular disease, including ischemic stroke and myocardial infarction. Shared pathophysiological mechanisms such as endothelial dysfunction, platelet aggregation, systemic inflammation, and autonomic imbalance suggest that migraine may act as an early clinical marker of systemic vascular vulnerability. Psychiatric comorbidities, frequently present in chronic migraine, further compound disability and may contribute to long-term cardiovascular risk. This narrative review discusses the evolving understanding of migraine as a multisystem disorder, emphasizing its vascular and neuropsychiatric dimensions. Emerging data on calcitonin gene-related peptide (CGRP)-targeting monoclonal antibodies highlight their efficacy not only in reducing headache burden but also their favorable cardiovascular safety profile. Moreover, preliminary evidence suggests these agents may have a positive effect on mood symptoms in patients with comorbid depression and anxiety. Recognizing migraine as a condition that intersects neurological, cardiovascular, and psychiatric pathways may support earlier risk stratification and guide integrated treatment approaches in complex patient populations.
- 20 June 2025
- Published by Springer Nature in Neurology and Therapy
- Vol. 14 (4) , 1229-1268
Open AccessFrom Headache to Heart Health: Investigating the Migraine–Cardiovascular Disease Connection
Migraine, particularly with aura, has been consistently associated with an increased risk of cardiovascular disease, including ischemic stroke and myocardial infarction. Shared pathophysiological mechanisms such as endothelial dysfunction, platelet aggregation, systemic inflammation, and autonomic imbalance suggest that migraine may act as an early clinical marker of systemic vascular vulnerability. Psychiatric comorbidities, frequently present in chronic migraine, further compound disability and may contribute to long-term cardiovascular risk. This narrative review discusses the evolving understanding of migraine as a multisystem disorder, emphasizing its vascular and neuropsychiatric dimensions. Emerging data on calcitonin gene-related peptide (CGRP)-targeting monoclonal antibodies highlight their efficacy not only in reducing headache burden but also their favorable cardiovascular safety profile. Moreover, preliminary evidence suggests these agents may have a positive effect on mood symptoms in patients with comorbid depression and anxiety. Recognizing migraine as a condition that intersects neurological, cardiovascular, and psychiatric pathways may support earlier risk stratification and guide integrated treatment approaches in complex patient populations.